Evidence map›Paper›PMID 34576177›Full record

ArticleInternational journal of molecular sciences2021

NGF Eye Administration Recovers the TrkB and Glutamate/GABA Marker Deficit in the Adult Visual Cortex Following Optic Nerve Crush.

Pamela Rosso, Elena Fico, Louise A Mesentier-Louro, Viviana Triaca, Alessandro Lambiase, Paolo Rama, Paola Tirassa

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Pamela RossoNational Research Council (CNR) of Italy, Institute of Biochemistry & Cell Biology (IBBC), Unit of Translational & Biomolecular Medicine "Rita Levi-Montalcini", Viale dell'Università 33, 00185 Rome, Italy.
Elena FicoNational Research Council (CNR) of Italy, Institute of Biochemistry & Cell Biology (IBBC), Unit of Translational & Biomolecular Medicine "Rita Levi-Montalcini", Viale dell'Università 33, 00185 Rome, Italy.
Louise A Mesentier-LouroDepartment of Ophthalmology, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Viviana TriacaNational Research Council (CNR) of Italy, Institute of Biochemistry & Cell Biology (IBBC), Unit of Translational & Biomolecular Medicine "Rita Levi-Montalcini", Viale dell'Università 33, 00185 Rome, Italy.ORCID 0000-0001-8290-7279
Alessandro LambiaseDepartment of Sense Organs, University Sapienza of Rome, Viale del Policlinico 155, 00161 Rome, Italy.ORCID 0000-0002-8974-991X
Paolo RamaSan Raffaele Hospital, Cornea and Ocular Surface Unit, Eye Repair Lab, Via Olgettina 60, 20132 Milano, Italy.
Paola TirassaNational Research Council (CNR) of Italy, Institute of Biochemistry & Cell Biology (IBBC), Unit of Translational & Biomolecular Medicine "Rita Levi-Montalcini", Viale dell'Università 33, 00185 Rome, Italy.
National Research Council · ITPoliclinico Umberto I · ITStanford University · USVita-Salute San Raffaele University · IT

Funding

Dompè pharmaceuticals spa t N.0002028 to Paola Tirassa
6 · The paper itself

Abstract

Eye-drop recombinant human nerve growth factor (ed-rhNGF) has proved to recover the retina and optic nerve damage in animal models, including the unilateral optic nerve crush (ONC), and to improve visual acuity in humans. These data, associated with evidence that ed-rhNGF stimulates the brain derived neurotrophic factor (BDNF) in retina and cortex, suggests that NGF might exert retino-fugal effects by affecting BDNF and its receptor TrkB. To address these questions, their expression and relationship with the GABAergic and glutamatergic transmission markers, GAD65 and GAD67, vesicular inhibitory amino acid transporter (VGAT), and vesicular glutamate transporters 1 and 2 (VGLUT-1 and VGLUT-2) were investigated in adult ONC rats contralateral and ipsilateral visual cortex (VCx). Ed-rhNGF recovers the ONC-induced alteration of GABAergic and glutamatergic markers in contralateral VCx, induces an upregulation of TrkB, which is positively correlated with BDNF precursor (proBDNF) decrease in both VCx sides, and strongly enhances TrkB+ cell soma and neuronal endings surrounded by GAD65 immuno-reactive afferents. These findings contribute to enlarging the knowledge on the mechanism of actions and cellular targets of exogenously administrated NGF, and suggest that ed-rhNGF might act by potentiating the activity-dependent TrkB expression in GAD+ cells in VCx following retina damage and/or ONC.

Indexed as

AnimalsBlotting, WesternEnzyme-Linked Immunosorbent Assaygamma-Aminobutyric AcidGlutamate DecarboxylaseGlutamic AcidMaleMicroscopy, ConfocalNerve Growth FactorNerve Growth FactorsRatsRecombinant ProteinsSynaptic TransmissionVesicular Glutamate Transport Protein 1Vesicular Glutamate Transport Protein 2Vesicular Inhibitory Amino Acid Transport Proteinscenegermingamma-Aminobutyric AcidGlutamate Decarboxylaseglutamate decarboxylase 1Glutamic AcidNerve Growth FactorNerve Growth FactorsRecombinant ProteinsSlc32a1 protein, ratVesicular Glutamate Transport Protein 1Vesicular Glutamate Transport Protein 2Vesicular Inhibitory Amino Acid Transport ProteinsBDNFGABAglutamateneurotrophinsoptic nerve crush (ONC)rat visual cortex (VCx)synaptic transmission

Identifiers

PMID34576177
PMCPMC8471133
OpenAlexW3199081573

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.